Semma Therapeutics

Semma Therapeutics

Semma Therapeutics is a biotechnology company making regenerative medicine therapies using stem cells.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

November 30, 2017
Semma Therapeutics raises a $114,000,000 series B round from Eight Roads Ventures.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Semma Therapeutics Series B round, November 2017
114,000,000
November 30, 2017
2 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

A startup looking to reverse type 1 diabetes just raised $114 million

Lydia Ramsey

Web

R.I. biotech firm, CytoSolv, acquired by Semma Therapeutics

Richard Asinof

Web

Documentaries, videos and podcasts

Title
Date
Link

Semma Therapeutics

October 18, 2018

Semma Therapeutics

October 24, 2017

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Research and Markets
January 7, 2021
www.prnewswire.com:443
/PRNewswire/ -- The "Stem Cell Therapy Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering....
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.